Pasteur Institute in Nha Trang, Nha Trang, Khanh Hoa, Vietnam.
Department of Pediatric Infectious Diseases Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
BMC Infect Dis. 2024 Aug 12;24(1):813. doi: 10.1186/s12879-024-09688-0.
Diphtheria is a re-emerging infectious disease and public health concern worldwide and in Vietnam with increasing cases in recent years. This study aimed to assess the anti-diphtheria toxoid antibodies status in Khanh Hoa Province and identify factors contributing to the vaccination policy in the south-central coast of Vietnam.
This was a cross-sectional study to evaluate the seroprevalence of anti-diphtheria toxoid antibodies among 1,195 participants, aged 5 - 40 years in Khanh Hoa Province, Vietnam. Immunoglobulin G antibody levels against diphtheria were detected using a commercial anti-diphtheria toxoid enzyme-linked immunosorbent assay (SERION ELISA classic Diphtheria Immunoglobulin G) and were categorized following the World Health Organization guidelines.
The mean anti-diphtheria toxoid antibody levels were 0.07 IU/ml (95% Confidence Interval: 0.07-0.08). Anti-diphtheria toxoid antibody levels were found to be associated with age and history of diphtheria vaccination. The 5-15 years age group had the highest levels (0.09 IU/ml), while the older age group had the lowest antibody level (p < 0.001). Individuals who received three doses (adjusted Odds ratio: 2.34, 95%CI: 1.35 - 4.07) or 4 doses (adjusted Odds ratio: 2.45, 95%CI: 1.29 - 4.64) had a higher antibody level compared to those who received only one dose regardless of age.
It is crucial to promote routine vaccination coverage to over 95% for children under one year of age with three primary doses of the diphtheria-containing vaccine, including additional doses at 18 months and 7 years of age. Booster doses should be promoted and administered to adolescents and adults every 10 years.
白喉是一种在全球范围内重新出现的传染病和公共卫生问题,在越南也是如此,近年来病例不断增加。本研究旨在评估庆和省抗白喉类毒素抗体状况,并确定导致越南中南部沿海地区疫苗接种政策的因素。
这是一项横断面研究,评估了越南庆和省 1195 名 5-40 岁参与者对白喉类毒素抗体的血清阳性率。使用商业抗白喉类毒素酶联免疫吸附试验(SERION ELISA 经典白喉免疫球蛋白 G)检测对白喉的免疫球蛋白 G 抗体水平,并按照世界卫生组织的指南进行分类。
平均抗白喉类毒素抗体水平为 0.07IU/ml(95%置信区间:0.07-0.08)。发现抗白喉类毒素抗体水平与年龄和白喉疫苗接种史有关。5-15 岁年龄组的抗体水平最高(0.09IU/ml),而年龄较大的组的抗体水平最低(p<0.001)。接受三剂(调整后的优势比:2.34,95%置信区间:1.35-4.07)或四剂(调整后的优势比:2.45,95%置信区间:1.29-4.64)的人,无论年龄大小,与仅接受一剂的人相比,抗体水平更高。
对于 1 岁以下的儿童,必须促进常规疫苗接种覆盖率达到 95%以上,接种三剂含白喉的疫苗,包括在 18 个月和 7 岁时额外接种一剂。应促进和为青少年和成年人每 10 年接种一次加强剂。